Trial NCT01598584

View at ClinicalTrials.gov 
Org. Study IDs: TJ20111123

Last trial update was posted on 2015-09-28

MeSH Interventions

Gemcitabine Mirtazapine

MeSH Conditions

Pancreatic Neoplasms

Other Conditions

Pancreatic Cancer

Stopping Reasons

Gemcitabine is not the first choice for most pancreatic cancer patients nowdays

Limitations And Caveats

N/A

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID